Sorrento Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2013 to Q2 2023.
  • Sorrento Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2023 was $2.67M, a 15.3% increase year-over-year.
  • Sorrento Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2023 was $6.81M, a 40.3% decline year-over-year.
  • Sorrento Therapeutics, Inc. annual Interest Expense for 2022 was $8.57M, a 16.1% decline from 2021.
  • Sorrento Therapeutics, Inc. annual Interest Expense for 2021 was $10.2M, a 49.3% decline from 2020.
  • Sorrento Therapeutics, Inc. annual Interest Expense for 2020 was $20.2M, a 42.5% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $6.81M $2.67M +$354K +15.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $6.46M $1.13M -$2.12M -65.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $8.57M $2.22M -$723K -24.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 $9.3M $792K -$2.11M -72.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $11.4M $2.31M +$298K +14.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $11.1M $3.25M +$883K +37.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $10.2M $2.94M +$448K +18% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $9.78M $2.9M +$338K +13.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $9.44M $2.02M -$6.28M -75.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $15.7M $2.37M -$4.44M -65.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $20.2M $2.49M -$4.5M -64.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 $24.7M $2.56M -$6.9M -72.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $31.5M $8.3M -$1.23M -12.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $32.8M $6.81M -$2.27M -25% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $35M $6.99M -$1.9M -21.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $36.9M $9.46M +$6.78M +252% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $30.2M $9.52M -$35.5M -78.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $65.7M $9.08M +$8.03M +763% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $57.6M $8.89M +$7.92M +823% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $49.7M $2.68M +$1.48M +122% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $48.2M $45M +$43.8M +3651% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $4.42M $1.05M -$557K -34.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $4.98M $963K +$169K +21.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 $4.81M $1.21M +$972K +412% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $3.84M $1.2M +$927K +340% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $2.91M $1.61M +$1.3M +424% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.61M $794K +$419K +112% Oct 1, 2016 Dec 31, 2016 8-K 2019-06-17
Q3 2016 $1.19M $236K -$160K -40.4% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-02-27
Q2 2016 $1.35M $273K -$169K -38.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.52M $307K -$132K -30.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.65M $375K -$87K -18.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $1.74M $396K -$80K -16.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.82M $442K -$26K -5.56% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $1.85M $439K +$216K +96.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $1.63M $462K +$292K +172% Oct 1, 2014 Dec 31, 2014 10-K/A 2017-03-27
Q3 2014 $1.34M $476K +$425K +833% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $912K $468K +$446K +2027% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $466K $223K +$213K +2130% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $253K $170K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $51K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $22K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $10K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.